| ASSET | YEAR | % RETURN |
|---|---|---|
Alibaba (BABA) | 2025 | 57.06% |
Philip Morris International (PM) | 2025 | 24.11% |
AbbVie (ABBV) | 2025 | 22.41% |
Abbott Laboratories (ABT) | 2025 | 21.45% |
T-Mobile US (TMUS) | 2025 | 20.41% |
Novartis AG ADR (NVS) | 2025 | 18.42% |
HSBC Holdings PLC ADR (HSBC) | 2025 | 17.71% |
AstraZeneca PLC ADR (AZN) | 2025 | 16.73% |
International Business Machines (IBM) | 2025 | 16.59% |
Johnson & Johnson (JNJ) | 2025 | 16.4% |
GE Aerospace (GE) | 2025 | 14.62% |
Coca-Cola (KO) | 2025 | 14.6% |
LIN TV (LIN) | 2025 | 9.82% |
McDonald’s (MCD) | 2025 | 9.67% |
Chevron (CVX) | 2025 | 9.51% |
Berkshire Hathaway (BRK.B) | 2025 | 9.02% |
Berkshire Hathaway (BRK.A) | 2025 | 8.74% |
Visa Inc Class A (V) | 2025 | 7.64% |
Shell PLC ADR (SHEL) | 2025 | 7.19% |
SAP SE ADR (SAP) | 2025 | 6.51% |
Eli Lilly and (LLY) | 2025 | 6.48% |
Procter & Gamble (PG) | 2025 | 5.5% |
Cisco Systems (CSCO) | 2025 | 5.42% |
Exxon Mobil (XOM) | 2025 | 4.18% |
PepsiCo (PEP) | 2025 | 3.11% |
Mega-cap stocks are treated as having a market cap of $200B+.
